Opening book details…
Can I read Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue on EtoBox?
Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue by Carsten Stephan; Monika Jung; Silke Rabenhorst; Ergin Kilic; Klaus Jung is a Medicine article available to read on EtoBox.
What is Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue about?
## Background: Micrornas (mirnas) have shown to be promising novel biomarkers in various cancers. we aimed to translate the results of an own previous tissue-based mirna profile of prostate carcinoma (pca) with upregulated mir-183 and downregulated mir-205 into a urine-based testing procedure for diagnosis of pca. ## Methods: Urine sediments were prepared from urine samples collected after a standardized digital-rectal examination (dre) of patients undergoing prostate biopsy with psa (prostate-specific antigen) values <20 μg/l in consecutive order. according to the sample-size calculation (α=0.05, power=0.95), 38 patients each with pca and without pca were randomly enrolled in this study. pca3 (prostate cancer associated 3) in urine as food and drug administration-approved assay was determined as reference standard for comparison. the mirnas were measured by rt-qpcr using taqman assays and normalized using different approaches. ## Results: Both mirnas were correlated to the mrna psa concentrations in the sediments indicating a relationship to the released prostate cells after dre. however, they had no discriminating capacity between patients with and without pca. in contrast, pca3
Who reads Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Carsten Stephan; Monika Jung; Silke Rabenhorst; Ergin Kilic; Klaus Jung
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Carsten Stephan; Monika Jung; Silke Rabenhorst; Ergin Kilic; Klaus Jung
Browse all works by Carsten Stephan; Monika Jung; Silke Rabenhorst; Ergin Kilic; Klaus Jung